Correlation Between Adial Pharmaceuticals and Centene Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Adial Pharmaceuticals and Centene Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adial Pharmaceuticals and Centene Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adial Pharmaceuticals and Centene Corp, you can compare the effects of market volatilities on Adial Pharmaceuticals and Centene Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adial Pharmaceuticals with a short position of Centene Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adial Pharmaceuticals and Centene Corp.

Diversification Opportunities for Adial Pharmaceuticals and Centene Corp

  Correlation Coefficient

Very good diversification

The 3 months correlation between Adial and Centene is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Adial Pharmaceuticals and Centene Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Centene Corp and Adial Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adial Pharmaceuticals are associated (or correlated) with Centene Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Centene Corp has no effect on the direction of Adial Pharmaceuticals i.e., Adial Pharmaceuticals and Centene Corp go up and down completely randomly.

Pair Corralation between Adial Pharmaceuticals and Centene Corp

Given the investment horizon of 90 days Adial Pharmaceuticals is expected to under-perform the Centene Corp. In addition to that, Adial Pharmaceuticals is 1.38 times more volatile than Centene Corp. It trades about -0.52 of its total potential returns per unit of risk. Centene Corp is currently generating about -0.35 per unit of volatility. If you would invest  9,144  in Centene Corp on June 30, 2022 and sell it today you would lose (1,414)  from holding Centene Corp or give up 15.46% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
ValuesDaily Returns

Adial Pharmaceuticals  vs.  Centene Corp

 Performance (%) 
Adial Pharmaceuticals 
Adial Performance
0 of 100
Over the last 90 days Adial Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with abnormal performance in the last few months, the Stock's forward indicators remain relatively steady which may send shares a bit higher in October 2022. The new chaos may also be a sign of medium-term up-swing for the company stakeholders.

Adial Price Channel

Centene Corp 
Centene Performance
0 of 100
Over the last 90 days Centene Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Centene Price Channel

Adial Pharmaceuticals and Centene Corp Volatility Contrast

   Predicted Return Density   

Pair Trading with Adial Pharmaceuticals and Centene Corp

The main advantage of trading using opposite Adial Pharmaceuticals and Centene Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adial Pharmaceuticals position performs unexpectedly, Centene Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Centene Corp will offset losses from the drop in Centene Corp's long position.
Adial Pharmaceuticals vs. Clearwater Paper Corp
The idea behind Adial Pharmaceuticals and Centene Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Centene Corp vs. Clearwater Paper Corp
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamental Analysis
View fundamental data based on most recent published financial statements
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities